A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

Japan's epigenetics market is evolving rapidly, with a strong emphasis on AI-driven research and personalized medicine, addressing complex diseases t ...

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

From a brain-inspired vision chip to an ice core time machine, these were the most important breakthroughs last year, ...

The global single cell multiomics market is set to experience a remarkable growth trajectory, projected to reach $14,369.5 million by 2031, with an impressive Compound Annual Growth Rate (CAGR) of ...

An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.

In the journal Nature Communications, Montana State University scientists in the College of Agriculture highlight fresh ...